CD86 and B-cell chronic lymphocytic leukemia: Finally, the percentage of CD86-expressing CLL cells in the peripheral blood remained an independent prognostic marker together with the IgVH mutation status in a multivariate analysis (p = 0.001 and p = 0.001; Table1).